The vacuum blood collection tube market size to reach $4,507.70 million by 2028 from $2,598.78 million in 2021 to grow at a CAGR of 8.2% from 2021 to 2028; while in 2021, serum separating tubes held largest market share and EDTA tubes segment expected to grow at the fastest rate in the coming years.
New York, Nov. 29, 2021 (GLOBE NEWSWIRE) -- According to our new research study on Vacuum Blood Collection Tube Market Size, Share, Revenue, Growth, Trends, Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Serum Separating Tubes, EDTA Tubes, Heparin Tubes, ESR Tubes, and Glucose Tubes), Material (PET, Polypropylene, and Tempered Glass), Application (Blood Routine Examination, Biochemical Test, and Coagulation Testing), and End User (Hospitals and Clinics, Ambulatory Surgical Centers, Pathology Labs, and Blood Banks), and Geography with COVID-19 Impact and Global Analysis available at https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00006202
No. of Charts & Figures
Product, Material, Application, and End User, and Geography
North America; Europe; Asia Pacific; Latin America; MEA
US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Vacuum Blood Collection Tube Market: Competition Landscape and Key Developments BD; Narang Medical Limited; Terumo Corporation; GPC Medical Ltd.; Vitrex Medical A/S; Medtronic; KALSTEIN FRANCE; ELITech Group; F.L. Medical; and STRECK, INC are among the key companies operating in the vacuum blood collection tube market. Leading market players are focusing on new product launch, expansion, diversification, and acquisition strategies, thereby tapping prevailing business opportunities.
Get Exclusive Sample Pages of Vacuum Blood Collection Tube Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at https://www.theinsightpartners.com/sample/TIPRE00006202/
In 2021, North America dominated the global vacuum blood collection tube market. The US held the largest share of the North American market in 2021. Favorable government programs and initiatives for blood donation, improved public awareness, rise in incidence of chronic diseases, upsurge in the research and development activities by the major key players, and advancements in vacuum blood collection tubes are a few factors propelling the market growth in North America.
The growing prevalence of behavioral disorders and increasing awareness of the available therapeutic options are major factors driving the growth of the vacuum blood collection tube market. The Anxiety and Depression Association of America (ADAA) states that anxiety disorders are the most common mental illness in the US, affecting 40 million adults of age 18 and above, i.e., 18.1% of the population each year..
Robust Advancements in Healthcare Facilities and Infrastructure Drive Vacuum Blood Collection Tube Market Growth: The prevalence of blood transfusion in major orthopedic and cardiovascular will spur the demand for vacuum blood collection tubes in North America. Also, a higher preference of people for contactless blood collection to avoid the risk of infection and contamination is driving the vacuum blood collection tube market. This will also lead to the demand for advanced healthcare infrastructure with improved facilities in the hospitals. Countries in North America are focusing on introducing advanced healthcare facilities and services to overcome critical health issues. Many pathology laboratories and diagnostic centers have initiated blood collection from home. Companies have launched home blood collection devices. Home blood collection has become popular during the pandemic due to movement restrictions and social distancing norms. For instance, in November 2020, a Seattle-based start-up, Tasso, launched a device to help patients painlessly collect their blood at home. According to the American Clinical Laboratory Association, 4,000 diagnostic tests are run 7 billion times a year in the US, so they figured the impact of such as product could be huge. The Casavant and Berthier duo created Hemolink, a wearable, minimally invasive device that lets patients collect blood samples from the comfort of their own homes.
Download Sample PDF Brochure of Vacuum Blood Collection Tube Market Size and Growth Research Report at https://www.theinsightpartners.com/sample/TIPRE00006202/
Moreover, the six major government healthcare programs—Medicare, Medicaid, the State Children's Health Insurance Program (SCHIP), the Department of Defense TRICARE and TRICARE for Life programs (DOD TRICARE), the Veterans Health Administration (VHA) program, and the Indian Health Service (IHS) program—provide healthcare services to about one-third of Americans. The federal government has the principal responsibility to ensure that ~US$ 500 billion invested annually in these programs are used wisely to reduce the burden of illness, injury, and disability and improve the population's health and functioning. The federal government must exercise strong leadership in addressing serious shortcomings in the US's safety and quality of health care. These government initiatives are likely to provide a lucrative opportunity for market players to introduce advanced technologies in vacuum blood collection tubes, which, in turn, will add to the growth of the vacuum blood collection tube market during the forecast period.
Vacuum Blood Collection Tube Market: Segmental Overview The global vacuum blood collection tube market, based on the product, is segmented into heparin tubes, EDTA tubes, glucose tubes, serum separating tubes, and ERS tubes. In 2021, the serum separating tubes segment held the largest share of the market. Moreover, the market for the EDTA tubes segment is expected to grow at the fastest rate during in the coming years.
The global vacuum blood collection tube market, based on the material, is segmented into PET, polypropylene, and tempered glass. In 2021, the PET segment held the largest share of the market. Moreover, the market for the same segment is also expected to grow at the fastest rate during in the coming years.
The global vacuum blood collection tube market, based on the application, is segmented into blood routine examination, biochemical test, and coagulation testing. In 2021, the blood routine examination segment held the largest share of the market. However, the market for the coagulation testing segment is also expected to grow at the fastest rate during in the coming years.
Based on end user, the vacuum blood collection tube market is segmented into hospitals and clinics, ambulatory surgical centers, pathology labs, and blood banks. The blood banks segment held the largest share of the market in 2021. Moreover, the same segment also is estimated to register the highest CAGR of 8.8% in the market during the forecast period.
Buy Premium Copy of Vacuum Blood Collection Tube Market Size, Share, Revenue, Strategic Insights and Forecasts 2021-2028 Research Report at https://www.theinsightpartners.com/buy/TIPRE00006202/
COVID Impacts: The North American economy is severely affected due to the exponential growth of COVID-19 cases in the region. The COVID-19 pandemic is expected to have an imperceptibly negative impact on the market. The COVID-19 pandemic and the subsequent economic downturn have had a detrimental effect on people's mental wellness and built new barriers for those who already have a mental illness or behavioral disorders. About 4 in 10 adults in the US have reported anxiety or depressive disorder signs during the pandemic, a number that has remained mostly steady, up from one in ten adults who had related symptoms from January to June 2019. Many adults are reporting specific adverse effects on their mental health and well-being as a result of worry and stress about the coronavirus, such as difficulty sleeping (36%), eating (32%), increasing alcohol consumption or substance use (12%), and worsening chronic conditions (12%), according to the KFF Health Tracking Poll from July 2020. As the epidemic progresses, continuing and required public health actions expose many people to scenarios connected to poor mental health outcomes, such as isolation and job loss.
About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us: If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi E-mail: sales@theinsightpartners.com Phone: +1-646-491-9876 Press Release - https://www.theinsightpartners.com/pr/vacuum-blood-collection-tube-market
Connect With Us on: LinkedIn: https://www.linkedin.com/company/7591674/admin/ Twitter: https://twitter.com/tipmarkettrends Facebook: https://www.facebook.com/theinsightpartners/ YouTube: https://www.youtube.com/c/TheInsightPartners RSS/Feeds: https://www.theinsightpartners.com/feed/ | https://www.openpr.com/news/archive/139407/The-Insight-Partners.html Research Study: https://www.einpresswire.com/newsroom/the_insight_partners/
The Oracle of Omaha knows how to beat inflation. So ride his coattails.
The Food and Drug Administration’s authorization of Pfizer (ticker: PFE) Covid-19 pill Paxlovid on Wednesday offered some hope. The authorization represents an extraordinary coup for Pfizer, its second of the pandemic. Analysts expect Pfizer to sell $21.7 billion worth of the drug in 2022, according to FactSet, though the company now says that it will make 120 million courses of the drug next year, 40 million more than previously forecast, which will probably drive those estimates higher.
Shares of Moderna (NASDAQ: MRNA) were down 3% as of 10:53 a.m. ET on Thursday after having been off by as much as 5.9% earlier. This move continued a downward trend that began Monday with concerns easing about the potential impact of the omicron variant of COVID-19. The combination of those study results and the FDA authorizations for oral COVID-19 therapies presents a double whammy for vaccine stocks other than Pfizer.
(Bloomberg) -- China’s reaffirmation of a long-term goal to be almost entirely self-sufficient in pork production means it will keep scooping up global grain supplies to feed the world’s largest pig herd. Most Read from BloombergOmicron May Double Risk of Getting Infected on Planes, IATA SaysOmicron Has 80% Lower Risk of Hospitalization in South AfricaThree Sinovac Doses Fail to Protect Against Omicron in StudySingapore's Travelers Face Omicron ChaosOmicron Hospitalization Risk Is Far Below Delt
Dr. David Katz, preventive medicine specialist and president at the True Health Initiative, reacts to the recent approval of COVID-19 pills from Pfizer and Merck, and how much of a difference the pills will make in combating COVID-19's spread.
Retail sales of new vehicles could fall 17.7% to 2,923,600 units from a year earlier, the report said. "Intense demand with this limited supply is resulting in prices continuing to increase," said Thomas King, president of the data and analytics division at J.D. Powers. Average transaction prices are expected to reach $45,743, going above the $45,000 mark for the first time, and 20% higher than December 2020 when prices first breached the $38,000 level.
Los Angeles County reported nearly 10,000 new coronavirus cases Friday as the highly infectious Omicron variant spread across California.
The crude oil markets initially fell during the week, but have since recovered completely to show signs of resiliency again
Dr. Angelique Coetzee, the South African doctor who is credited with helping to spot the omicron variant, offers a few intriguing findings about the strain.
Oil and gas exchange-traded funds (ETFs) offer investors more direct and easier access to the often-volatile energy market than many other alternatives. While there is the potential for significant returns by investing in the oil and gas sector, the risks can be high.
Global oil demand roared back in 2021 as the world began to recover from the coronavirus pandemic, and overall world consumption potentially could hit a new record in 2022 - despite efforts to bring down fossil fuel consumption to mitigate climate change. For 2022, crude consumption is expected to reach 99.53 million barrels per day (bpd), up from 96.2 million bpd this year, according to the International Energy Agency. Numerous OPEC nations have struggled to add to output, while the U.S. shale industry has to deal with investor demands to hold the line on spending.
(Bloomberg) -- Record-high power and gas prices have crippled energy suppliers worldwide, leaving some running at a loss and causing many to collapse altogether.Most Read from BloombergOmicron May Double Risk of Getting Infected on Planes, IATA SaysOmicron Has 80% Lower Risk of Hospitalization in South AfricaThree Sinovac Doses Fail to Protect Against Omicron in StudySingapore's Travelers Face Omicron ChaosOmicron Hospitalization Risk Is Far Below Delta’s in Two StudiesEnergy providers are closi
State health officials said they are preparing to receive two newly approved antiviral medications to treat COVID-19 "within the coming weeks."
Natural gas markets initially rallied during the week but got hammered yet again as temperatures in the United States are not helping the situation.
Crude oil markets have continued to rally as we head into the holiday weekend.
Pfizer's pending acquisition of Arena Pharma includes Olorinab, a candidate that acts with the cannabinoid type 2 receptor to treat gastrointestinal disorders.
Yahoo Finance's Dan Howley explains what exactly web3 is, how companies and brands are planning to use that online space, and the criticisms tech leaders such as Jack Dorsey are lobbing at venture capitalist firms investing into the platform.
Andrea Arriaga Borges tested positive for COVID-19 on May 19, 2021. The mother of five told KCRA 3 she had no underlying health issues, does not have asthma and does not smoke. Six days later, the Cameron Park woman asked her husband to call 911 when she couldn't breathe or walk. The last thing she remembers is talking to family before being intubated at the hospital. "That's all I remember," she said. "And then I was in a coma for two months." See more in the video above.
(Bloomberg) -- Intel Corp.’s global push to increase capacity will include adding facilities in France and Italy, as well as putting a major production site in Germany, according to people familiar with negotiations. Most Read from BloombergLarry Summers Predicts the Future, and It Doesn’t Look GoodSingapore's Travelers Face Omicron ChaosUnited and Delta Cancel Hundreds of Christmas FlightsThree Sinovac Doses Fail to Protect Against Omicron in StudyHundreds of Flights Canceled; U.K. Cases at Rec
Women in Mississippi, the worst state for a baby to be born, have an unintended pregnancy rate of 47.1%. That’s 17.5% higher than the national average.